Kyto Technology and Life Science, Inc. (KBPH) Stock

About Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.

Kyto Technology and Life Science, Inc. is headquartered in US.

Kyto Technology and Life Science, Inc. (KBPH) stock trades at $1.00 with a market capitalization of $13.29M. The stock is valued at a price-to-earnings (P/E) ratio of 16.67, price-to-book of 0.97, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.00 and $1.00, and currently trades at or near its 52-week high.

On profitability, Kyto Technology and Life Science, Inc. generates a return on equity (ROE) of 8.84%, return on capital employed of -21.25%.

Official website: k2x.capital